ALS and the gut microbiome, part two: What can we actually do with this science?
Original source
ALS and the gut microbiome, part two: What can we actually do with this science? (opens in a new tab)You Nutrition Clinic has a commercial interest in this subject. Compass summarises the reporting; it is not independent analysis, and it is not clinical evidence.
Gut-focused approaches, including diet, prebiotics, probiotics and other microbiome-based treatments, remain experimental in ALS. The review says animal studies and some human findings are promising, but there is not yet proof that these approaches slow disease progression, improve symptoms or extend life. It emphasises protecting calorie and protein intake, swallowing safety and body weight before making major dietary changes.
Why this matters
People with ALS may be considering gut-focused diets or supplements. The review supports paying attention to nutrition, bowel symptoms and food tolerance, but does not support treating fibre, fermented foods or other microbiome approaches as established ALS therapies.
Limitations and context
This is an expert review from a sponsored clinic, not a new clinical trial. It discusses an emerging field in which causality is not established, and the supplied source text ends partway through the article. Human evidence described in the review includes observational research, which cannot show that particular foods change ALS outcomes.